Suppr超能文献

糖皮质激素对肌成纤维/脂肪祖细胞分化的双刃剑效应。

Janus effect of glucocorticoids on differentiation of muscle fibro/adipogenic progenitors.

机构信息

Department of Biology, University of Rome "Tor Vergata", Rome, Italy.

Department of Biology, IRBM S.p.A., via Pontina Km 30,600, 00071, Pomezia (Roma), Italy.

出版信息

Sci Rep. 2020 Mar 24;10(1):5363. doi: 10.1038/s41598-020-62194-6.

Abstract

Muscle resident fibro-adipogenic progenitors (FAPs), support muscle regeneration by releasing cytokines that stimulate the differentiation of myogenic stem cells. However, in non-physiological contexts (myopathies, atrophy, aging) FAPs cause fibrotic and fat infiltrations that impair muscle function. We set out to perform a fluorescence microscopy-based screening to identify compounds that perturb the differentiation trajectories of these multipotent stem cells. From a primary screen of 1,120 FDA/EMA approved drugs, we identified 34 compounds as potential inhibitors of adipogenic differentiation of FAPs isolated from the murine model (mdx) of Duchenne muscular dystrophy (DMD). The hit list from this screen was surprisingly enriched with compounds from the glucocorticoid (GCs) chemical class, drugs that are known to promote adipogenesis in vitro and in vivo. To shed light on these data, three GCs identified in our screening efforts were characterized by different approaches. We found that like dexamethasone, budesonide inhibits adipogenesis induced by insulin in sub-confluent FAPs. However, both drugs have a pro-adipogenic impact when the adipogenic mix contains factors that increase the concentration of cAMP. Gene expression analysis demonstrated that treatment with glucocorticoids induces the transcription of Gilz/Tsc22d3, an inhibitor of the adipogenic master regulator PPARγ, only in anti-adipogenic conditions. Additionally, alongside their anti-adipogenic effect, GCs are shown to promote terminal differentiation of satellite cells. Both the anti-adipogenic and pro-myogenic effects are mediated by the glucocorticoid receptor and are not observed in the presence of receptor inhibitors. Steroid administration currently represents the standard treatment for DMD patients, the rationale being based on their anti-inflammatory effects. The findings presented here offer new insights on additional glucocorticoid effects on muscle stem cells that may affect muscle homeostasis and physiology.

摘要

肌内成纤维-脂肪生成祖细胞(FAP)通过释放细胞因子刺激肌源性干细胞的分化来支持肌肉再生。然而,在非生理环境(肌病、萎缩、衰老)中,FAP 会导致纤维化和脂肪浸润,从而损害肌肉功能。我们着手进行荧光显微镜筛选,以鉴定干扰这些多能干细胞分化轨迹的化合物。在对 1120 种 FDA/EMA 批准的药物进行初步筛选后,我们从杜氏肌营养不良症(DMD)的小鼠模型中分离出的 FAP 中发现 34 种化合物可能是成脂分化的抑制剂。该筛选的命中化合物列表出人意料地富含糖皮质激素(GC)化学类别的化合物,这些药物已知在体外和体内促进脂肪生成。为了阐明这些数据,我们通过不同的方法对筛选中发现的三种 GC 进行了表征。我们发现,与地塞米松一样,布地奈德抑制胰岛素诱导的 FAP 成脂分化。然而,当脂肪生成混合物包含增加 cAMP 浓度的因子时,这两种药物都具有促进脂肪生成的作用。基因表达分析表明,糖皮质激素处理仅在抗脂肪生成条件下诱导脂肪生成主调控因子 PPARγ 的转录因子 Gilz/Tsc22d3 的转录。此外,除了具有抗脂肪生成作用外,GC 还促进卫星细胞的终末分化。GC 的这些抗脂肪生成和促肌生成作用均由糖皮质激素受体介导,在存在受体抑制剂时则观察不到。类固醇给药目前是 DMD 患者的标准治疗方法,其依据是其抗炎作用。这里提出的发现提供了关于糖皮质激素对肌肉干细胞的其他影响的新见解,这些影响可能影响肌肉的动态平衡和生理学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b1a/7093513/1abf5d5cd70b/41598_2020_62194_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验